Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;43(6):1091-1098.
doi: 10.1007/s10096-024-04825-8. Epub 2024 Apr 12.

Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center

Lisa Piasecki  1 , Charlotte Genestet  1 , Yvonne Benito  1 , Jean-Philippe Rasigade  1 , Gérard Lina  1 , Oana Dumitrescu  1 , Elisabeth Hodille  2
Affiliations

Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center

Lisa Piasecki et al. Eur J Clin Microbiol Infect Dis. 2024 Jun.

Abstract

Purpose: Rapid, reliable identification of mycobacteria from positive cultures is essential for patient management, particularly for the differential diagnosis of Mycobacterium tuberculosis complex (MTBC) and nontuberculous mycobacteria (NTM) species. The aim of the present study was to evaluate a new "In-Vitro-Diagnostic"-certified PCR kit, FluoroType®-Mycobacteria VER 1.0 (Hain Lifescience GmbH) for NTM and MTBC identification from cultures.

Methods: Mycobacteria identification isolated from positive cultures during routine practice at the Lyon university hospital mycobacteria laboratory obtained by hsp65 amplification/sequencing were compared retrospectively and prospectively to those obtained by and the FluoroType®-Mycobacteria VER 1.0 kit.

Results: The overall agreement between hsp65 amplification/sequencing and the FluoroType®-Mycobacteria VER 1.0 kit was 88.4% (84/95); 91.2% (52/57) for the retrospective period and 84.2% (32/38) for the prospective period. There were 9 (9.5%) minor discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified at genus level): 4 during the retrospective period, 5 during the prospective period; and 2 (2.1%) major discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified incorrectly to species level): 1 during the retrospective period (M. kumamotonense identified as M. abscessus subsp massiliense by the kit) and 1 during the prospective period (M. chimaera identified as M. smegmatis by the kit). Including concordant results at genus level and minor discrepancies, 17.9% (17/95) of strains were identified as Mycobacterium sp. by the FluoroType®-Mycobacteria-VER 1.0 kit.

Conclusion: The good performance of the FluoroType®-Mycobacteria-VER 1.0 kit with few major discrepancies could enable its use for first-line identification of positive mycobacteria cultures. However, an alternative identification method at least for reference laboratories is needed owing to the non-negligible proportion of NTM strains were identified at genus level.

Keywords: Fluorotype®-Mycobacteria VER 1.0; Identification; Nontuberculous mycobacteria.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Global tuberculosis report 2022 [Internet]. [cited 2023 29];doi: https://www.who.int/publications-detail-redirect/9789240061729
    1. Dahl VN, Mølhave M, Fløe A, van Ingen J, Schön T, Lillebaek T et al (2022) Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis IJID off Publ Int Soc Infect Dis 125:120–131. https://doi.org/10.1016/j.ijid.2022.10.013 - DOI
    1. Koh W-J, Nontuberculous, Mycobacteria—Overview (2017) 27;5 Microbiol. Spectr. : https://doi.org/10.1128/microbiolspec.tnmi7-0024-2016 . doi: 10.1128/microbiolspec.tnmi7-0024-2016
    1. Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson M-C, Salfinger M et al (2018) Practice guidelines for clinical Microbiology Laboratories: Mycobacteria. Clin Microbiol Rev 31. https://doi.org/10.1128/CMR.00038-17
    1. Huh HJ, Kim S-Y, Shim HJ, Kim DH, Yoo IY, Kang O-K et al (2019) GenoType NTM-DR performance evaluation for identification of Mycobacterium avium Complex and Mycobacterium abscessus and determination of Clarithromycin and Amikacin Resistance. J Clin Microbiol 57:e00516–e00519. https://doi.org/10.1128/JCM.00516-19 - DOI - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources